These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30242706)

  • 1. Generating Intracellular Modulators of E3 Ligases and Deubiquitinases from Phage-Displayed Ubiquitin Variant Libraries.
    Zhang W; Sidhu SS
    Methods Mol Biol; 2018; 1844():101-119. PubMed ID: 30242706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ubiquitination and deubiquitination in tumor invasion and metastasis.
    Han S; Wang R; Zhang Y; Li X; Gan Y; Gao F; Rong P; Wang W; Li W
    Int J Biol Sci; 2022; 18(6):2292-2303. PubMed ID: 35414786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression.
    Zheng C; Chen J; Wu Y; Wang X; Lin Y; Shu L; Liu W; Wang P
    Front Immunol; 2023; 14():1217466. PubMed ID: 37359559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme reversal to explore the function of yeast E3 ubiquitin-ligases.
    MacDonald C; Winistorfer S; Pope RM; Wright ME; Piper RC
    Traffic; 2017 Jul; 18(7):465-484. PubMed ID: 28382714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between bacterial deubiquitinase and ubiquitin E3 ligase regulates ubiquitin dynamics on Legionella phagosomes.
    Liu S; Luo J; Zhen X; Qiu J; Ouyang S; Luo ZQ
    Elife; 2020 Nov; 9():. PubMed ID: 33136002
    [No Abstract]   [Full Text] [Related]  

  • 6. Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases.
    Roscow O; Zhang W
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34515691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for modulation of enzymes in the ubiquitin system.
    Ernst A; Avvakumov G; Tong J; Fan Y; Zhao Y; Alberts P; Persaud A; Walker JR; Neculai AM; Neculai D; Vorobyov A; Garg P; Beatty L; Chan PK; Juang YC; Landry MC; Yeh C; Zeqiraj E; Karamboulas K; Allali-Hassani A; Vedadi M; Tyers M; Moffat J; Sicheri F; Pelletier L; Durocher D; Raught B; Rotin D; Yang J; Moran MF; Dhe-Paganon S; Sidhu SS
    Science; 2013 Feb; 339(6119):590-5. PubMed ID: 23287719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Deubiquitinase Specificity and Regulation.
    Mevissen TET; Komander D
    Annu Rev Biochem; 2017 Jun; 86():159-192. PubMed ID: 28498721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted modulation of E3 ligases using engineered ubiquitin variants.
    LeBlanc N; Mallette E; Zhang W
    FEBS J; 2021 Apr; 288(7):2143-2165. PubMed ID: 32867007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and Characterization of Engineered Ubiquitin Variants to Modulate the Ubiquitin Signaling Cascade.
    Liang CT; Roscow O; Zhang W
    Cold Spring Harb Protoc; 2024 Apr; 2024(4):107784. PubMed ID: 36997275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of T helper cell differentiation by E3 ubiquitin ligases and deubiquitinating enzymes.
    Gao SF; Zhong B; Lin D
    Int Immunopharmacol; 2017 Jan; 42():150-156. PubMed ID: 27914308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting E3 Ubiquitin Ligases and Deubiquitinases in Ciliopathy and Cancer.
    Shiromizu T; Yuge M; Kasahara K; Yamakawa D; Matsui T; Bessho Y; Inagaki M; Nishimura Y
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy.
    Liu Q; Aminu B; Roscow O; Zhang W
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination: Friend and foe in cancer.
    Mansour MA
    Int J Biochem Cell Biol; 2018 Aug; 101():80-93. PubMed ID: 29864543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A High-Throughput Screening Strategy for Development of RNF8-Ubc13 Protein-Protein Interaction Inhibitors.
    Weber E; Rothenaigner I; Brandner S; Hadian K; Schorpp K
    SLAS Discov; 2017 Mar; 22(3):316-323. PubMed ID: 27909234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?
    Zou M; Zeng QS; Nie J; Yang JH; Luo ZY; Gan HT
    Front Immunol; 2021; 12():769167. PubMed ID: 34956195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of deubiquitination in nucleotide excision repair.
    Zhang L; Gong F
    DNA Repair (Amst); 2016 Aug; 44():118-122. PubMed ID: 27316462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Isomeric Phosphoubiquitin Chains Reveals that Phosphorylation Controls Deubiquitinase Activity and Specificity.
    Huguenin-Dezot N; De Cesare V; Peltier J; Knebel A; Kristaryianto YA; Rogerson DT; Kulathu Y; Trost M; Chin JW
    Cell Rep; 2016 Jul; 16(4):1180-1193. PubMed ID: 27425610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and advance of ubiquitination and deubiquitination in depression pathogenesis and treatment.
    Yan X; Ma Y; Yang J; Chang X; Shi S; Song G
    Drug Dev Res; 2024 Nov; 85(7):e70005. PubMed ID: 39417355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.